Expanding home blood pressure monitoring among US adults with hypertension could substantially reduce the burden of cardiovascular disease and save healthcare costs in the long term, according to a new study in the American Journal of Preventive Medicine, published by Elsevier.
Aridis to delist from Nasdaq; Bicycle closes $200M+ offering
Aridis Pharmaceuticals is being taken off the Nasdaq, effective Wednesday. The biotech reported the news in an SEC filing Monday, saying that it will be